These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 5582479)
21. [Blood myoglobin in children with progressive muscular dystrophy and in carriers]. Calandi C; Baretti S; Pacciani G; Bagni P; Borsotti M; Tozzi P; Adami Lami C Quad Sclavo Diagn; 1984 Dec; 20(4):391-8. PubMed ID: 6537549 [TBL] [Abstract][Full Text] [Related]
22. The value of plasma cholinesterase in children with severe liver disease. Popović L; Mikecin L; Kern J Eur J Anaesthesiol; 2009 Apr; 26(4):352-4. PubMed ID: 19401671 [No Abstract] [Full Text] [Related]
23. Serum cholinesterase variants: examination of several differential inhibitors, salts, and buffers used to measure enzyme activity. Garry PJ Clin Chem; 1971 Mar; 17(3):183-91. PubMed ID: 5100960 [No Abstract] [Full Text] [Related]
24. [Role of the liver in the pathogenesis of progressive muscular dystrophy in children]. Grinio LP; Shakhgnil'dian IV; Braginskiĭ DM; Bezprozvannyĭ BK Vopr Okhr Materin Det; 1973 Oct; 18(10):15-8. PubMed ID: 4785359 [No Abstract] [Full Text] [Related]
25. [Atypical cholinesterase. A survey of 2 Danish families]. Hanel HK; Mogensen JV Nord Med; 1971 Jan; 85(4):109-13. PubMed ID: 5101548 [No Abstract] [Full Text] [Related]
26. Determination of serum cholinesterase activity and dibucaine numbers by an amperometric choline sensor. Palleschi G; Lavagnini MG; Moscone D; Pilloton R; D'Ottavio D; Evangelisti ME Biosens Bioelectron; 1990; 5(1):27-35. PubMed ID: 2178637 [TBL] [Abstract][Full Text] [Related]
27. [Congenital muscular dystrophy]. Mumenthaler M Z Kinderheilkd; 1969; 106(2):131-62. PubMed ID: 5802055 [No Abstract] [Full Text] [Related]
28. [The mechanism of inhibition of serum cholinesterase by various drugs. 1]. Sato N Iryo; 1969 May; 23(5):641-5. PubMed ID: 5805714 [No Abstract] [Full Text] [Related]
29. [Study on progressive muscular dystrophy. 1. Influence of the various drugs on serum enzyme activity and the degree of disability]. Kanno M; Annaka S; Sato N; Shinoda M Iryo; 1968 Dec; 22(12):1364-71. PubMed ID: 5717702 [No Abstract] [Full Text] [Related]
30. [Estimation of the probability of heterozygosity in Duchenne-type progressive muscular dystrophy]. Guízar Vázquez J; Navarrete Cadena C; Rico R; Mora G; Zavala C Bol Med Hosp Infant Mex; 1981; 38(1):23-33. PubMed ID: 7284070 [TBL] [Abstract][Full Text] [Related]
31. [Serum cholinesterase. A comparison of two methods for determination]. Schmidinger S; Doenicke A Z Klin Chem Klin Biochem; 1966 Nov; 4(6):273-81. PubMed ID: 5994632 [No Abstract] [Full Text] [Related]
32. [Evaluation of serum pyruvate kinase in patients with Duchenne's muscular dystrophy and carriers. Comparison with other enzyme determinations]. Calandi C; Adami Lami C; Guidotti T; Nistri R; Papuzza S; Tozzi P; Poggi G Minerva Pediatr; 1981 May; 33(10):453-64. PubMed ID: 7254147 [No Abstract] [Full Text] [Related]
33. [Long term observations in muscular dystrophy. Therapeutic influence of disease course in progressive muscular dystrophy (8 long term observations)]. Schlenska GK; Kleine TO Med Welt; 1980 Jun; 31(25):940-4. PubMed ID: 6775171 [No Abstract] [Full Text] [Related]
34. [Progressive muscular dystrophy]. Uono M No To Shinkei; 1970 Sep; 22(9):1002-6. PubMed ID: 5536074 [No Abstract] [Full Text] [Related]
35. Dibucaine number measured with the Ektachem. Cattozzo G; Franzini C; Rettondini M Clin Chem; 1993 Jul; 39(7):1545-6. PubMed ID: 8330416 [No Abstract] [Full Text] [Related]
36. The prevalence of atypical serum cholinesterase in a Nigerian population. Ukoha AI; Nwoke UN; Rahman MM; Alam MS Trop Geogr Med; 1987 Apr; 39(2):169-72. PubMed ID: 3629711 [TBL] [Abstract][Full Text] [Related]
37. [Present status of progressive muscular dystrophy]. Koyama N Iryo; 1967 Jul; 21(7):779-85. PubMed ID: 5582472 [No Abstract] [Full Text] [Related]
38. [Electrocardiographic findings in the Duchenne-type of progressive muscular dystrophy]. Nakagawa K; Okamoto S; Goto H; Kato T; Yamamoto K Iryo; 1968 Dec; 22(12):1425-38. PubMed ID: 5717711 [No Abstract] [Full Text] [Related]
39. The inhibition of serum cholinesterase by urea. Mechanism of action and application in the typing of abnormal genes. Hanel HK; Viby-Mogensen J Br J Anaesth; 1977 Dec; 49(12):1251-7. PubMed ID: 588402 [TBL] [Abstract][Full Text] [Related]